X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (704) 704
Patent (91) 91
Publication (82) 82
Book Review (48) 48
Conference Proceeding (42) 42
Book Chapter (3) 3
Book / eBook (2) 2
Web Resource (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (317) 317
index medicus (239) 239
humans (231) 231
female (210) 210
breast cancer (207) 207
middle aged (135) 135
breast neoplasms - drug therapy (126) 126
adult (112) 112
aged (109) 109
breast neoplasms - pathology (103) 103
chemotherapy (102) 102
obstetrics & gynecology (86) 86
prognosis (86) 86
cancer (84) 84
chemistry (71) 71
biochemistry (70) 70
beer (69) 69
enzymology (69) 69
metallurgy (69) 69
microbiology (69) 69
mutation or genetic engineering (69) 69
spirits (69) 69
vinegar (69) 69
wine (69) 69
compositions or test papers therefor (67) 67
condition-responsive control in microbiological orenzymological processes (67) 67
measuring or testing processes involving enzymes, nucleicacids or microorganisms (67) 67
processes of preparing such compositions (67) 67
further section · weitere sektionen (60) 60
therapy (59) 59
treatment outcome (54) 54
disease-free survival (52) 52
metastasis (52) 52
antineoplastic combined chemotherapy protocols - therapeutic use (51) 51
breast neoplasms - metabolism (50) 50
breast neoplasms - mortality (50) 50
care and treatment (50) 50
physics (48) 48
women (47) 47
aged, 80 and over (46) 46
survival (46) 46
diagnosis (45) 45
human necessities (45) 45
hygiene (45) 45
medical or veterinary science (45) 45
surgery (45) 45
adjuvant chemotherapy (42) 42
health aspects (42) 42
medicine & public health (42) 42
breast neoplasms - genetics (41) 41
chemotherapy, adjuvant (40) 40
trastuzumab (40) 40
calculating (39) 39
computing (39) 39
counting (39) 39
further section (38) 38
neoplasm staging (38) 38
research (38) 38
hematology, oncology and palliative medicine (37) 37
electric digital data processing (34) 34
clinical trials (33) 33
medizin (33) 33
prospective studies (33) 33
risk factors (33) 33
endocrine therapy (31) 31
trial (31) 31
adjuvant treatment (30) 30
antineoplastic agents - therapeutic use (29) 29
breast neoplasms - surgery (29) 29
identification (29) 29
survival analysis (29) 29
metastatic breast cancer (27) 27
tamoxifen (27) 27
expression (26) 26
investigating or analysing materials by determining theirchemical or physical properties (26) 26
measuring (26) 26
testing (26) 26
breast neoplasms - therapy (25) 25
neoplasm metastasis (25) 25
biomarkers, tumor - analysis (24) 24
neoadjuvant therapy (24) 24
quality of life (24) 24
cancer therapies (23) 23
drug therapy (23) 23
follow-up (23) 23
analysis (22) 22
biomarkers, tumor - metabolism (22) 22
breast neoplasms - diagnosis (22) 22
computer systems based on specific computational models (22) 22
gene expression (22) 22
receptor, erbb-2 - metabolism (22) 22
anthracyclines (21) 21
antineoplastic combined chemotherapy protocols - adverse effects (21) 21
combination (21) 21
docetaxel (21) 21
oncology, experimental (21) 21
pai-1 (21) 21
compositions thereof (20) 20
culture media (20) 20
immunohistochemistry (20) 20
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet, ISSN 0140-6736, 03/2017, Volume 389, Issue 10074, pp. 1134 - 1150
Breast cancer is one of the three most common cancers worldwide. Early breast cancer is considered potentially curable. Therapy has progressed substantially... 
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 4, pp. 425 - 439
Journal Article
MMW Fortschritte der Medizin, ISSN 1438-3276, 2003, Volume 145, Issue 3-4, pp. 8 - 10
Journal Article
The Lancet, ISSN 0140-6736, 03/2017, Volume 389, Issue 10074, p. 1134
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1016/S0140-6736(16)31891-8... 
Medical colleges | Adjuvant treatment | Breast cancer | Metastasis | Health aspects | Cancer
Journal Article
The Lancet, ISSN 0140-6736, 03/2017, Volume 389, Issue 10074, p. 1134
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/S0140-6736(16)31891-8 Byline: Nadia Harbeck (a), Michael Gnant (b)... 
Adjuvant treatment | Breast cancer | Metastasis | Health aspects | Cancer
Journal Article
The Lancet, ISSN 0140-6736, 03/2017, Volume 389, Issue 10074, p. 1134
Journal Article
The Lancet, ISSN 0140-6736, 03/2017, Volume 389, Issue 10074, pp. 1134 - 1150
Breast cancer is one of the three most common cancers worldwide. Early breast cancer is considered potentially curable. Therapy has progressed substantially... 
Journal Article
The Lancet, ISSN 0140-6736, 03/2017, Volume 389, Issue 10074, p. 1134
Breast cancer is one of the three most common cancers worldwide. Early breast cancer is considered potentially curable. Therapy has progressed substantially... 
Adjuvant treatment | Breast cancer | Metastasis | Health aspects | Cancer
Journal Article
The Lancet, ISSN 0140-6736, 03/2017, Volume 389, Issue 10074, p. 1134
Journal Article
The Lancet, ISSN 0140-6736, 03/2017, Volume 389, Issue 10074, p. 1134
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1016/S0140-6736(16)31891-8... 
Medical colleges | Adjuvant treatment | Breast cancer | Metastasis | Health aspects | Cancer
Journal Article
The Lancet, ISSN 0140-6736, 03/2017, Volume 389, Issue 10074, p. 1134
  Breast cancer is one of the three most common cancers worldwide. Early breast cancer is considered potentially curable. Therapy has progressed substantially... 
Chemotherapy | Ultrasonic imaging | Surgical techniques | Womens health | Mortality | Surgery | Mammography | Breast cancer | Metastasis | Cancer therapies | Patients | Tumors
Journal Article
The Lancet, ISSN 0140-6736, 03/2017, Volume 389, Issue 10074, p. 1134
Breast cancer is one of the three most common cancers worldwide. Early breast cancer is considered potentially curable. Therapy has progressed substantially... 
Adjuvant treatment | Breast cancer | Metastasis | Health aspects | Cancer
Journal Article
The Lancet, ISSN 0140-6736, 03/2017, Volume 389, Issue 10074, p. 1134
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1016/S0140-6736(16)31891-8... 
Medical colleges | Adjuvant treatment | Breast cancer | Metastasis | Health aspects | Cancer
Journal Article
The Lancet, ISSN 0140-6736, 03/2017, Volume 389, Issue 10074, pp. 1134 - 1150
Journal Article
Nature reviews. Clinical oncology, ISSN 1759-4774, 01/2012, Volume 9, Issue 1, pp. 10 - 12
Journal Article
best practice onkologie, ISSN 0946-4565, 2/2018, Volume 13, Issue 1, pp. 24 - 30
Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 02/2012, Volume 9, Issue 2, p. 66
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2015, Volume 373, Issue 3, pp. 209 - 219
In women with hormone-receptor–positive metastatic breast cancer that had progressed after endocrine therapy, palbociclib plus fulvestrant was associated with... 
TARGET | MEDICINE, GENERAL & INTERNAL | THERAPY | FULVESTRANT | CLINICAL-TRIALS | CYCLIN D | RESISTANCE | MUTATIONS | COMBINATION | ESTROGEN-RECEPTOR | 4/6 INHIBITOR PALBOCICLIB | Cyclin-Dependent Kinase 6 - antagonists & inhibitors | Estradiol - analogs & derivatives | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Receptors, Estrogen - analysis | Protein Kinase Inhibitors - adverse effects | Receptors, Progesterone - analysis | Pyridines - adverse effects | Aged, 80 and over | Estradiol - adverse effects | Adult | Female | Cyclin-Dependent Kinase 4 - antagonists & inhibitors | Pyridines - therapeutic use | Double-Blind Method | Estradiol - therapeutic use | Biomarkers - analysis | Piperazines - therapeutic use | Breast Neoplasms - drug therapy | Piperazines - adverse effects | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Aged | Receptor, ErbB-2 - analysis | Women | Hormone receptors | Care and treatment | Usage | Breast cancer | Diagnosis | Health aspects | Thrombocytopenia | Leukopenia | Endocrine therapy | Fatigue | Metastasis | Cancer therapies | Cyclin-dependent kinase 4 | Fulvestrant | Metastases | Epidermal growth factor | Womens health | S phase | Cell cycle | Neutropenia | G1 phase | Index Medicus | Abridged Index Medicus
Journal Article
gynäkologie + geburtshilfe, ISSN 1439-3557, 09/2017, Volume 22, Issue S1, pp. 32 - 38
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.